A Long-term, Open-label Study to Evaluate the Safety,Pharmacodynamics, and Efficacy of Migalastat in Subjects > 12 Years of Age with Fabry Disease and Amenable GLA Variants

Project: Research project

Project Details

Description

A Long-term, Open-label Study to Evaluate the Safety, Pharmacodynamics, and Efficacy of Migalastat in Subjects > 12 Years of Age with Fabry Disease and Amenable GLA Variants
StatusActive
Effective start/end date1/6/211/5/27

Funding

  • Amicus Therapeutics

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.